Driving Therapeutic Antibody Discovery with Artificial Intelligence

Learn how scientists integrate computational biology and experimental data to accelerate antibody drug development.

During antibody discovery, researchers characterize and optimize thousands of antibody molecules to select ideal drug candidates. Artificial intelligence/machine learning (AI/ML) technologies provide new opportunities for identifying and generating high-quality antibody drugs in less time. In this webinar brought to you by Integrated DNA Technologies, Charbel Eid from BigHat Biosciences will discuss an innovative AI/ML platform that guides antibody design and accelerates the discovery of better antibody therapeutics.

Topics to be covered

  • A novel integrated AI/ML-wet lab platform
  • How AI/ML enables faster antibody discovery 

Monday, September 12th, 2022 | 2:30 PM - 3:30 PM Eastern Time
This webinar will be available to view live and on demand.


Charbel Eid

Charbel Eid, PhD

Head of Platform Development
BigHat Biosciences

Sponsored by